Author

David Wu

University of Michigan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:zebrafish· 1

Frequent Co-Authors

Allison C. FergusoniD· 1 shared Clayton J. HabigeriD· 1 shared David A. HanaueriD· 1 shared Hongyu Su· 1 shared Jacqueline K. Lee· 1 shared Jason C. RechiD· 1 shared Jenny Xun· 1 shared Jordan A. ShavitiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Allison C. FergusonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

FDA-approved drug repurposing in zebrafish identifies thyroid hormone and other compounds as potential antithrombotics

Murat Yaman, Hongyu Su, Jacqueline K. Lee, Allison C. Ferguson, Katherine M Sowell, Jenny Xun, David Wu, Clayton J. Habiger, David A. Hanauer, Martin C. Clasby, Jason C. Rech, Jordan A. Shavit

This study uses zebrafish to screen FDA-approved drugs for antithrombotic effects, identifying thyroid hormone and others as potential treatments for VTE subtypes.

bioRxiv · Sep 23, 2025 · PreprintPharmacology & Toxicology